AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05837806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tislelizumab+disitamab-vedotin
Description: patients in group will receive 3 cycles of tislelizumab 200 mg in combination with disitamab-vedotin 120 mg intravenously.
Study NCT06509204 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glucotrojan
Description: Day 1: Start wearing the CGM sensor and let it self-calibrate for 24 h Day 2: Consume 1 serving of Test Meal for breakfast. Log the meal in the app. Day 3: Consume 1 serving of Test Meal with GlucoTrojan for breakfast. Log the meal in the app.~Days 4-8: Participants will be instructed to take GlucoTrojan twice per day. Once during their typical breakfast meal and once during their typical dinner meal. Each breakfast and dinner will be logged in the app.~Days 9-13: Participants will continue with their typical lives but continue to log meals - breakfast and dinner - in the app.~Day 14: end
Study NCT05701579 — intervention group
Intervention type: PROCEDURE
Intervention: ACL decompression
Description: The technique of ACL decompression by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.
Study NCT05697536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates training
Description: It consists of patients who will receive pilates exercise training sessions 3 times per week for 8 weeks. Every session will be of 45 minutes. Exercise programs follow the basic principles of pilates method but particularly movements with low and medium difficulty levels will be chosen to adapt the program to the physical capacity of the patients.~Protocol will be compromise of 9 modules: postural education, search for neutral position, sitting exercise, antalgic exercise, stretching exercises, proprioceptively improvement exercises and breathing exercises.
Study NCT05697536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: It consists of patients who will receive aerobic exercise sessions 3 times per week for 8 weeks. Every session will be of 45 minutes.~It will include warm up phase, active phase and
Study NCT04648215 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lavender oil
Description: aromatherapy--two drops applied to a 2x2 gauze and pinned to subject's gown
Study NCT04648215 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Grapeseed Oil
Description: aromatherapy--two drops applied to a 2 X 2 gauze and pinned to subject's gown
Study NCT05763615 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tractography MRI
Description: Addition to the sequences usually done for the care of these patients (CubeT2, Diffusion, CubeT1, CubeT2 fiesta, ASL, T1 injected with gadolinium), of a so-called research tractography sequence benefiting from CE marking and not requiring specific injection.~Search sequence acquisition time: 10 minutes.
Study NCT04972227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CY6463
Description: oral tablets
Study NCT04972227 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral tablets
Study NCT05980650 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki implication
Description: Reiki will be implicate by researcher by putting hands on patient
Study NCT06127394 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sacral ESP Block
Description: Sacral ESPB median approach, 40 ml %0,25 Bupivacaine
Study NCT06127394 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pudendal Block
Description: Bilateral pudendal block, 10 ml %0,25 bupivacaine
Study NCT05499091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Skin biopsy, blood sample, urine sample
Description: blood samples, urine samples, skin samples.
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CANUT support
Description: CANUT support includes delivery of the CANUT guide (food guide developed by Paul Bocuse Institute from previous results) ; it will be given to patient with explanations about the use of the guide. This also includes 2 calls from a dietician, performed between the 1st and the 3rd chemotherapy cycle to help patient personally with their food side effects.
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anthropometric measures
Description: These measures include weight, waist size, hip size and brachial circumference
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anthropometric measures
Description: These measures include weight, waist size, hip size and brachial circumference
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Prehension strength measurement
Description: Prehension strength will be assessed thanks to a hand grip device, that makes it possible to measure strength of all fingers, hands, wrists and forearms muscles
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehension strength measurement
Description: Prehension strength will be assessed thanks to a hand grip device, that makes it possible to measure strength of all fingers, hands, wrists and forearms muscles
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: QVA Questionnaire
Description: Food quality of life questionnaire
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: QVA Questionnaire
Description: Food quality of life questionnaire
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: QLQ C30 Questionnaire
Description: Quality of Life questionnaire Core 30
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: QLQ C30 Questionnaire
Description: Quality of Life questionnaire Core 30
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Scratch & Snif Test
Description: The Scratch \& Snif Test is used to assess olfactory capacities : patient has to scratch a box on a card, smell it and recognize the scent amongst a list of propositions
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scratch & Snif Test
Description: The Scratch \& Snif Test is used to assess olfactory capacities : patient has to scratch a box on a card, smell it and recognize the scent amongst a list of propositions
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Taste Strip Test
Description: The Taste Strip Test is used to assess taste capacities : strips impregnated with different concentrations of the 5 basic taste qualities (sweet, sour, acid, bitter, umami) are successively placed on patient's tongue ; patient has to identify the taste bit by bit.
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Taste Strip Test
Description: The Taste Strip Test is used to assess taste capacities : strips impregnated with different concentrations of the 5 basic taste qualities (sweet, sour, acid, bitter, umami) are successively placed on patient's tongue ; patient has to identify the taste bit by bit.
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 24 H feed back questionnaire
Description: This questionnaire describes patient's food and drink intakes during the last 24 ours
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 24 H feed back questionnaire
Description: This questionnaire describes patient's food and drink intakes during the last 24 ours
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Condiment questionnaire
Description: This questionnaire used to assess condiments consumption
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Condiment questionnaire
Description: This questionnaire used to assess condiments consumption
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tobacco questionnaire
Description: This questionnaire used to assess tobacco consumption
Study NCT05027490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco questionnaire
Description: This questionnaire used to assess tobacco consumption
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition interview
Description: This interview will be conducted by a dietician
Study NCT05027490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutrition interview
Description: This interview will be conducted by a dietician
Study NCT05679167 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supervised digital training with focus on core stability
Description: After randomization, Group 1 will be digitally supervised by experienced physiotherapist.
Study NCT05679167 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supervised digital training with focus on aerobic exercise
Description: After randomization Group 2 will be digitally supervised by experienced physiotherapist.
Study NCT05679167 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-supervised daily physical activity
Description: After randomization Group 3 will receive training instruction regarding daily physical activity.
Study NCT04963530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Treatment with monolithic zirconia restorations
Description: Treatment with monolithic zirconia restorations on teeth (single crowns). The sample (75 patients) will be divided into three groups according to the ceramic material used: monolithic zirconia, lithium disilicate and metal ceramic.
Study NCT04963530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Treatment with lithium disilicate restorations
Description: Treatment with lithium disilicate restorations on teeth (single crowns). The sample (75 patients) will be divided into three groups according to the ceramic material used: monolithic zirconia, lithium disilicate and metal ceramic.
Study NCT04963530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Treatment with metal ceramic restorations
Description: Treatment with metal ceramic restorations on teeth (single crowns). The sample (75 patients) will be divided into three groups according to the ceramic material used: monolithic zirconia, lithium disilicate and metal ceramic.
Study NCT04963530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No intervention
Description: No intervention.
Study NCT05347927 — intervention group
Intervention type: DEVICE
Intervention: water resistante padding
Description: * Delta-Dry® Softliner~* Tensoban®~* Delta-Dry®
Study NCT05347927 — intervention group
Intervention type: DEVICE
Intervention: non water resistante padding
Description: * Delta-Net® Stockinette~* Delta-Rol®
Study NCT05150171 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: e-self-management intervention
Description: The app is developed based on a combination of behavioural change techniques informed by Social cognitive theory and the EULAR recommendations on management of hand osteoarthritis. The 12-week intervention consists of 25 short informational videos addressing the themes prioritized by the patient research partners. Additionally, the intervention includes a hand exercise program consisting of 8 videos providing instructions on warm up, exercises to improve mobility, strength and coordination, and a stretching exercise. The informational videos and exercise program are delivered in a progressive order across the 12 weeks. Encouragement and motivational messages are provided each week to enhance continued adherence to the intervention.
Study NCT05785325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC48-ADC plus Bevacizumab
Description: Administer RC48-ADC intravenously in combination with bevacizumab 5mg/kg once every two weeks.
Study NCT06227988 — intervention group
Intervention type: PROCEDURE
Intervention: patients with liver disease who undergoing surgery
Description: For each patient and surgery, we will be collecting detailed pre-operative data regarding demographics (age, sex, body mass index, surgery category, comorbidities (diabetes mellitus, hypertension), and pertinent laboratory values (sodium, creatinine, total bilirubin, the international normalized ratio \[INR\], albumin, platelet count.) The etiology of liver disease will be classified.~To ensure that laboratory data accurately reflected the pre-operative state, only those from within 30 days prior to surgery will be considered For each patient VOCAL PENN score, MELD score, and Mayo score will be calculated using an online calculator.
Study NCT06227988 — intervention group
Intervention type: PROCEDURE
Intervention: patients with liver disease who do not undergoing surgery
Description: For each patient and surgery, we will be collecting detailed pre-operative data regarding demographics (age, sex, body mass index, surgery category, comorbidities (diabetes mellitus, hypertension), and pertinent laboratory values (sodium, creatinine, total bilirubin, the international normalized ratio \[INR\], albumin, platelet count.) The etiology of liver disease will be classified.~To ensure that laboratory data accurately reflected the pre-operative state, only those from within 30 days prior to surgery will be considered For each patient VOCAL PENN score, MELD score, and Mayo score will be calculated using an online calculator.
Study NCT04622163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Secondary Mentor
Description: Subjects will be matched with a secondary mentor from the Department of Medicine for 6 months. Mentors and mentees are expected to hold one-on-one meetings monthly for the first 3 months followed by at least once every 3 months thereafter.
Study NCT04622163 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Career Development Resources
Description: Subjects will receive career development resources.
Study NCT04622163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Career Development Resources
Description: Subjects will receive career development resources.
Study NCT05499767 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HEPPI
Description: Homebound Elderly People Psychotherapeutic Intervention
Study NCT05785637 — intervention group
Intervention type: PROCEDURE
Intervention: Polygraphy diagnostic at home
Description: Polygraphy diagnostic at home for patients under non-invasive mechanical ventilation.
Study NCT04931290 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Supracapsular Ahmed Glaucoma Valve plate delivery technique
Description: incision of the perilimbal superior temporal conjunctiva with separation of the conjunctiva from the Tenon's capsule till reaching the encapsulated valve plate. Incision of the capsule in a z pattern will be done then the plate is dissected from the tissues and delivered out of the capsule through the opening to the subconjunctival space.The mobility of AGV and its tube will be evaluated and refixation of the plate will be done if needed. The plate will be covered with ologen implant sizing 12mm width and 1 mm thickness. The conjunctiva will be closed by 10/0 nylon sutures.
Study NCT05594069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: triple pre-rehabilitation
Description: The triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out from the time of enrollment (T0). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.
Study NCT05594069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: triple rehabilitation
Description: The triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out at the time of the beginning of radiotherapy (T1), and the middle stage of radiotherapy (T2). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.
Study NCT05594069 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: triple rehabilitation
Description: The triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out at the time of the beginning of radiotherapy (T1), and the middle stage of radiotherapy (T2). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.
Study NCT04774900 — intervention group
Intervention type: PROCEDURE
Intervention: Administration of oxygen
Description: Administration of high-flow oxygen via face mask to a high fidelity mannequin.
Study NCT04774900 — intervention group
Intervention type: PROCEDURE
Intervention: Administration of drug in a nebulizer
Description: Administration of bronchodilator via nebulizer mask to a high fidelity mannequin.
Study NCT04774900 — intervention group
Intervention type: PROCEDURE
Intervention: Securing intravenous line
Description: Securing an intravenous line at the forearm of high fidelity mannequin.
Study NCT04774900 — intervention group
Intervention type: PROCEDURE
Intervention: Administration of IV drug
Description: Administration of bronchodilator via IV line to a high fidelity mannequin.
Study NCT04774900 — intervention group
Intervention type: PROCEDURE
Intervention: Needle decompression of tension pneumothorax
Description: Needle decompression of tension pneumothorax on a high fidelity mannequin.
Study NCT05420220 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
Description: 5 mg/kg Q3W IV
Study NCT05420220 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Axitinib
Description: 5mg bid po
Study NCT05059223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AXS-12 (reboxetine)
Description: AXS-12 tablets, taken twice daily
Study NCT05059223 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets, taken twice daily
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Squaric Acid Dibutyl Ester
Description: Sensitization dose: 2% Elicitation doses: {0.0001%, 0.00025%, 0.00075%, 0.001%, 0.0025%, 0.005%, 0.0075%, 0.01%, 0.025%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6% 0.7%, 0.8%, 0.9%, 1.0%, 1.2%, 1.4%, 1.6%, 1.8%, 2.0%}
Study NCT05535738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Known patch test allergens
Description: Positive patch test allergens during the course of clinical patch testing will be re-applied on the back followed by skin sampling
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: 300mg
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab
Description: 40mg
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Description: 45mg
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Guselkumab
Description: 100mg
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canakinumab
Description: 150mg
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sarilumab
Description: 200mg
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triamcinolone Acetonide
Description: 0.1% ointment
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betamethasone Valerate
Description: 0.1% ointment
Study NCT05535738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone Propionate
Description: 0.005% ointment
Study NCT05535738 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microneedle
Description: Painless and non-scarring skin sampling with a 7mm x 7mm patch of hydrogel-coated poly-l-lactide microneedles (\<2mm length) will be used to collect interstitial fluid
Study NCT05535738 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Suction blistering
Description: Suction blistering is a technique to induce and collect blister fluid using a negative pressure instrument (Electronic Diversities Finksburg, MD). It does not require local anesthetic, stitches or pain medication following the procedure. The blisters will be no greater than 1cm in diameter and no deeper than the epidermis (\<1mm deep). This process of inducing blisters is typically less than 1 hour. After the formation of blisters, the blister fluid will be extracted using a syringe. The blister roofs will be left attached to the skin and covered with petrolatum and a bandage.
Study NCT05535738 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Skin punch biopsy
Description: A skin biopsy is the removal of a small piece of tissue, under local anesthetic.
Study NCT05743075 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ensifentrine
Description: A dual PDE3/PDE 4 inhibitor
Study NCT06218355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensive Education
Description: Intervention will consist of virtual education and communication through scheduled push notifications
Study NCT06218355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Virtual Care
Description: Intervention will utilize a telehealth model consisting of pull approach of patient engagement.
Study NCT04658095 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: OMNI® Surgical System
Description: Ab-interno canaloplasty (360 degrees) and up to 360 degrees trabeculotomy using the OMNI Surgical System